S I D E B A R
Format
Items per page
Sort by

Download:

Choose Destination

Links from PubMed

Items: 1 to 100 of 193

VariationLocationGene(s)Condition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:610093
GRCh38:
Chr5:609978
LOC100996325vincristine response - Toxicity/ADRdrug response
(Feb 23, 2017)
reviewed by expert panel
2.
GRCh37:
Chr7:117171028
GRCh38:
Chr7:117530974
CFTRivacaftor response - Efficacydrug response
(Mar 22, 2018)
reviewed by expert panel
3.
GRCh37:
Chr10:96705223
GRCh38:
Chr10:94945466
CYP2C9warfarin response - Dosagedrug response
(Feb 27, 2018)
reviewed by expert panel
4.
GRCh37:
Chr11:116663707
GRCh38:
Chr11:116792991
APOA5atorvastatin response - Efficacy, simvastatin response - Efficacy, lovastatin response - Efficacy
drug response
(May 14, 2018)
reviewed by expert panel
5.
GRCh37:
Chr13:28624294
GRCh38:
Chr13:28050157
FLT3sunitinib response - Toxicity/ADRdrug response
(Dec 7, 2017)
reviewed by expert panel
6.
GRCh37:
Chr2:54395259
GRCh38:
Chr2:54168122
ACYP2cisplatin response - Toxicity/ADRdrug response
(Dec 7, 2017)
reviewed by expert panel
7.
GRCh37:
Chr9:86909550
GRCh38:
Chr9:84294635
SLC28A3anthracyclines and related substances response - Toxicity/ADRdrug response
(Dec 20, 2017)
reviewed by expert panel
8.
GRCh37:
Chr9:86900926
GRCh38:
Chr9:84286011
SLC28A3anthracyclines and related substances response - Toxicity/ADRdrug response
(Dec 20, 2017)
reviewed by expert panel
9.
GRCh37:
Chr7:117280015
GRCh38:
Chr7:117639961
CFTRataluren response - Efficacydrug response
(Mar 23, 2016)
reviewed by expert panel
10.
GRCh37:
Chr5:63258565
GRCh38:
Chr5:63962738
HTR1Anot specified, paroxetine response - Efficacydrug response
(Dec 20, 2017)
reviewed by expert panel
11.
GRCh37:
Chr15:78888400
GRCh38:
Chr15:78596058
CHRNA3nicotine response - Toxicity/ADR, Metabolism/PKdrug response
(Apr 12, 2016)
reviewed by expert panel
12.
GRCh37:
Chr10:96741054
GRCh38:
Chr10:94981297
CYP2C9warfarin response - Dosagedrug response
(Dec 20, 2017)
reviewed by expert panel
13.
GRCh37:
Chr18:673444-673449
GRCh38:
Chr18:673444-673449
TYMS, ENOSF1capecitabine response - Efficacy, fluorouracil response - Efficacydrug response
(Jan 11, 2018)
reviewed by expert panel
14.
GRCh37:
Chr19:41515702
GRCh38:
Chr19:41009797
CYP2B6efavirenz response - Metabolism/PKdrug response
(Dec 20, 2017)
reviewed by expert panel
15.
GRCh37:
Chr1:154548880
GRCh38:
Chr1:154576404
CHRNB2nicotine response - Efficacy, Toxicity/ADRdrug response
(Dec 5, 2017)
reviewed by expert panel
16.
GRCh37:
Chr17:61565890-61565891
GRCh38:
Chr17:63488529-63488530
ACEcaptopril response - Efficacydrug response
(Dec 20, 2017)
reviewed by expert panel
17.
GRCh37:
Chr19:39734923
GRCh38:
Chr19:39244283
IFNL3peginterferon alfa-2a response - Efficacy, peginterferon alfa-2b response - Efficacy, ribavirin response - Efficacy
drug response
(Jun 14, 2016)
reviewed by expert panel
18.
GRCh37:
Chr2:85777633
GRCh38:
Chr2:85550510
GGCXwarfarin response - Dosagedrug response
(Apr 5, 2018)
reviewed by expert panel
19.
GRCh37:
Chr12:21382619
GRCh38:
Chr12:21229685
SLCO1B1methotrexate response - Toxicity/ADRdrug response
(Dec 20, 2017)
reviewed by expert panel
20.
GRCh37:
Chr11:113283688
GRCh38:
Chr11:113412966
DRD2Dystonia, cocaine response - Toxicity/ADRdrug response
(Apr 13, 2016)
reviewed by expert panel
21.
GRCh37:
Chr10:96798749
GRCh38:
Chr10:95038992
CYP2C8rosiglitazone response - Metabolism/PKdrug response
(Mar 28, 2017)
reviewed by expert panel
22.
GRCh37:
Chr8:18257795
GRCh38:
Chr8:18400285
NAT2ethambutol, isoniazid, pyrazinamide, and rifampin response - Toxicity/ADRdrug response
(Oct 27, 2017)
reviewed by expert panel
23.
GRCh37:
Chr22:44324727
GRCh38:
Chr22:43928847
PNPLA3cyclophosphamide response - Toxicity/ADR, Susceptibility to Nonalcoholic Fatty Liver Disease, asparaginase response - Toxicity/ADR,
daunorubicin response - Toxicity/ADR, prednisolone response - Toxicity/ADR, vincristine response - Toxicity/ADR
drug response
(Nov 27, 2017)
reviewed by expert panel
24.
GRCh37:
Chr15:51502844
GRCh38:
Chr15:51210647
CYP19A1, PIRC66, MIR4713HGAromatase deficiency, cyclophosphamide response - Efficacy, docetaxel response - Efficacy,
paclitaxel response - Efficacy, fluorouracil response - Efficacy, anastrozole response - Efficacy,
doxorubicin response - Efficacy, epirubicin response - Efficacy, exemestane response - Efficacy,
radiotherapy response - Efficacy, tamoxifen response - Efficacy ...see more
drug response
(Feb 6, 2018)
reviewed by expert panel
25.
GRCh37:
Chr12:48272895
GRCh38:
Chr12:47879112
VDRnot specified, Vitamin D-Dependent Rickets, peginterferon alfa-2b and ribavirin response - Efficacy
drug response
(Mar 1, 2017)
reviewed by expert panel
26.
GRCh37:
Chr16:31107689
GRCh38:
Chr16:31096368
VKORC1acenocoumarol response - Dosage, phenprocoumon response - Dosage, warfarin response - Dosage,
warfarin response - Efficacy, warfarin response - Toxicity/ADR, acenocoumarol response - Toxicity/ADR
drug response
(Apr 26, 2018)
reviewed by expert panel
27.
GRCh37:
Chr2:234668570
GRCh38:
Chr2:233759924
UGT1A, UGT1A10, UGT1A8, UGT1A7, UGT1A6, UGT1A5, UGT1A9, UGT1A4, UGT1A1, UGT1A3atazanavir response - Otherdrug response
(Mar 23, 2018)
reviewed by expert panel
28.
GRCh37:
Chr2:234668881-234668882
GRCh38:
Chr2:233760235-233760236
UGT1A, UGT1A10, UGT1A8, UGT1A7, UGT1A6, UGT1A5, UGT1A9, UGT1A4, UGT1A1, UGT1A3SN-38 response - Other, atazanavir and ritonavir response - Toxicity/ADR, irinotecan response - Toxicity/ADR
drug response
(Mar 14, 2018)
reviewed by expert panel
29.
GRCh37:
Chr19:39743165
GRCh38:
Chr19:39252525
IFNL3interferons, peginterferon alfa-2a, peginterferon alfa-2b, and ribavirin response - Efficacy, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, and telaprevir response - Efficacydrug response
(Oct 16, 2017)
reviewed by expert panel
30.
GRCh37:
Chr16:31104509
GRCh38:
Chr16:31093188
VKORC1not specified, warfarin response - Dosagedrug response
(Dec 11, 2017)
reviewed by expert panel
31.
GRCh37:
Chr13:47411985
GRCh38:
Chr13:46837850
HTR2AMajor depressive disorder, response to citalopram therapy in, not specified, antidepressants response - Efficacy,
citalopram response - Efficacy, Selective serotonin reuptake inhibitors response - Efficacy
drug response
(Oct 15, 2015)
reviewed by expert panel
32.
GRCh37:
Chr10:96702066
GRCh38:
Chr10:94942309
CYP2C9warfarin response - Dosage, Toxicity/ADRdrug response
(Feb 4, 2016)
reviewed by expert panel
33.
GRCh37:
Chr7:30726777
GRCh38:
Chr7:30687161
CRHR2selective beta-2-adrenoreceptor agonists response - Efficacy, salbutamol response - Efficacydrug response
(Jul 5, 2017)
reviewed by expert panel
34.
GRCh37:
Chr7:80532112
GRCh38:
Chr7:80902796
SEMA3Cirinotecan response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
35.
GRCh37:
Chr7:99270539
GRCh38:
Chr7:99672916
CYP3A5, ZSCAN25cyclosporine response - Dosage, Metabolism/PK, sirolimus response - Dosage, tacrolimus response - Efficacy,
tacrolimus response (donor genotype) - Dosage, Metabolism/PK, tacrolimus response (recipient genotype) - Dosage, Metabolism/PK, sirolimus response - Metabolism/PK
drug response
(Mar 20, 2018)
reviewed by expert panel
36.
GRCh37:
Chr2:159899489
GRCh38:
Chr2:159042977
TANC1radiotherapy response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
37.
GRCh37:
Chr6:31114182
GRCh38:
Chr6:31146405
CCHCR1nevirapine response - Toxicity/ADRdrug response
(Jun 22, 2016)
reviewed by expert panel
38.
GRCh37:
Chr5:179220638
GRCh38:
Chr5:179793637
LTC4Saspirin response - Toxicity/ADRdrug response
(Oct 28, 2015)
reviewed by expert panel
39.
GRCh37:
Chr12:69824024
GRCh38:
Chr12:69430244
YEATS4hydrochlorothiazide response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
40.
GRCh37:
Chr16:31102321
GRCh38:
Chr16:31091000
VKORC1acenocoumarol response - Dosage, phenprocoumon response - Dosage, warfarin response - Dosage,
Vitamin K-Dependent Clotting Factors
drug response
(Dec 11, 2017)
reviewed by expert panel
41.
GRCh37:
Chr16:31110981
GRCh38:
Chr16:31099660
VKORC1warfarin response - Dosagedrug response
(Dec 11, 2017)
reviewed by expert panel
42.
GRCh37:
Chr16:55857570
GRCh38:
Chr16:55823658
CES1clopidogrel response - Efficacydrug response
(Oct 28, 2015)
reviewed by expert panel
43.
GRCh37:
Chr11:103418158
GRCh38:
Chr11:103547430
DYNC2H1Platinum compounds response - Toxicity/ADR, etoposide response - Toxicity/ADRdrug response
(Oct 14, 2015)
reviewed by expert panel
44.
GRCh37:
Chr8:139884509
GRCh38:
Chr8:138872266
COL22A1salbutamol response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
45.
GRCh37:
Chr7:154072020
GRCh38:
Chr7:154374935
DPP6antipsychotics response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
46.
GRCh37:
Chr2:159899913
GRCh38:
Chr2:159043401
TANC1radiotherapy response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
47.
GRCh37:
Chr4:69681936
GRCh38:
Chr4:68816218
UGT2B10nicotine response - Metabolism/PKdrug response
(Jun 3, 2016)
reviewed by expert panel
48.
GRCh37:
Chr1:169519049
GRCh38:
Chr1:169549811
F5not provided, hormonal contraceptives for systemic use response - Toxicity/ADRdrug response
(Nov 28, 2017)
reviewed by expert panel
49.
GRCh37:
Chr17:4836381
GRCh38:
Chr17:4933086
GP1BAnot specified, aspirin response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
50.
GRCh37:
Chr12:6954875
GRCh38:
Chr12:6845711
GNB3, CDCA3sildenafil response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
51.
GRCh37:
Chr18:57882787
GRCh38:
Chr18:60215554
MC4Ramisulpride response - Toxicity/ADR, aripiprazole response - Toxicity/ADR, clozapine response - Toxicity/ADR,
haloperidol response - Toxicity/ADR, olanzapine response - Toxicity/ADR, paliperidone response - Toxicity/ADR,
quetiapine response - Toxicity/ADR, risperidone response - Toxicity/ADR, ziprasidone response - Toxicity/ADR
drug response
(Jun 22, 2016)
reviewed by expert panel
52.
GRCh37:
Chr19:41512792
GRCh38:
Chr19:41006887
CYP2B6efavirenz response - Metabolism/PKdrug response
(Dec 11, 2017)
reviewed by expert panel
53.
GRCh37:
Chr6:35669983
GRCh38:
Chr6:35702206
FKBP5antidepressants response - Efficacy, citalopram response - Efficacy, fluoxetine response - Efficacy,
Selective serotonin reuptake inhibitors response - Efficacy, mirtazapine response - Efficacy, paroxetine response - Efficacy,
venlafaxine response - Efficacy
drug response
(Oct 14, 2015)
reviewed by expert panel
54.
GRCh37:
Chr4:84192168
GRCh38:
Chr4:83271015
COQ2atorvastatin response - Toxicity/ADR, hmg coa reductase inhibitors response - Toxicity/ADR, rosuvastatin response - Toxicity/ADR
drug response
(Oct 14, 2015)
reviewed by expert panel
55.
GRCh37:
Chr2:216212339
GRCh38:
Chr2:215347616
ATICmethotrexate response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
56.
GRCh37:
Chr4:110834110
GRCh38:
Chr4:109912954
EGFcetuximab response - Efficacy, Renal Hypomagnesemia, Recessivedrug response
(Feb 1, 2018)
reviewed by expert panel
57.
GRCh37:
Chr10:96725535
GRCh38:
Chr10:94965778
CYP2C9warfarin response - Dosagedrug response
(Feb 24, 2015)
reviewed by expert panel
58.
GRCh37:
Chr18:55816791
GRCh38:
Chr18:58149559
NEDD4Ldiuretics response - Efficacy, hydrochlorothiazide response - Efficacydrug response
(Apr 7, 2016)
reviewed by expert panel
59.
GRCh37:
Chr12:21283322
GRCh38:
Chr12:21130388
SLCO1B1pravastatin response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
60.
GRCh37:
Chr1:161514542
GRCh38:
Chr1:161544752
FCGR3Anot specified, rituximab response - Efficacy, trastuzumab response - Efficacy
drug response
(Jul 11, 2016)
reviewed by expert panel
61.
GRCh37:
Chr2:234580454
GRCh38:
Chr2:233671808
UGT1A, UGT1A10, UGT1A8, UGT1A9SN-38 response - Otherdrug response
(Jul 11, 2016)
reviewed by expert panel
62.
GRCh37:
ChrX:113818520
GRCh38:
ChrX:114584047
HTR2Cantipsychotics response - Toxicity/ADRdrug response
(Dec 20, 2017)
reviewed by expert panel
63.
GRCh37:
Chr1:78956432
GRCh38:
Chr1:78490747
PTGFRlatanoprost response - Efficacydrug response
(Jan 21, 2015)
reviewed by expert panel
64.
GRCh37:
Chr19:39739154-39739155
GRCh38:
Chr19:39248514-39248515
IFNL4boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir, and telaprevir response - Efficacydrug response
(Dec 11, 2017)
reviewed by expert panel
65.
GRCh37:
Chr7:128399224
GRCh38:
Chr7:128759170
CALUwarfarin response - Dosagedrug response
(Jul 11, 2016)
reviewed by expert panel
66.
GRCh37:
Chr19:45912736
GRCh38:
Chr19:45409478
ERCC1, CD3EAPcisplatin response - Toxicity/ADR, Platinum compounds response - Toxicity/ADR, platinum response - Toxicity/ADR
drug response
(Jun 27, 2016)
reviewed by expert panel
67.
GRCh37:
Chr2:208494234
GRCh38:
Chr2:207629510
buprenorphine response - Dosage, fentanyl response - Dosage, meperidine response - Dosage,
morphine response - Dosage, opioids response - Dosage, pentazocine response - Dosage
drug response
(Oct 14, 2015)
reviewed by expert panel
68.
GRCh37:
Chr19:41518221
GRCh38:
Chr19:41012316
CYP2B6efavirenz response - Metabolism/PK, nevirapine response - Other, nevirapine response - Toxicity/ADR
drug response
(Dec 5, 2017)
reviewed by expert panel
69.
GRCh37:
Chr10:96741058
GRCh38:
Chr10:94981301
CYP2C9not provided, warfarin response - Dosagedrug response
(Nov 6, 2017)
reviewed by expert panel
70.
GRCh37:
Chr16:31105554
GRCh38:
Chr16:31094233
VKORC1warfarin response - Dosagedrug response
(Jul 11, 2016)
reviewed by expert panel
71.
GRCh37:
Chr2:159929431
GRCh38:
Chr2:159072919
TANC1radiotherapy response - Toxicity/ADRdrug response
(Feb 13, 2018)
reviewed by expert panel
72.
GRCh37:
Chr2:159950865
GRCh38:
Chr2:159094353
TANC1radiotherapy response - Toxicity/ADRdrug response
(Feb 13, 2018)
reviewed by expert panel
73.
GRCh37:
Chr2:159936391
GRCh38:
Chr2:159079879
TANC1radiotherapy response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
74.
GRCh37:
Chr19:44055726
GRCh38:
Chr19:43551574
XRCC1carboplatin response - Efficacy, cisplatin response - Efficacy, Platinum compounds response - Efficacy,
oxaliplatin response - Efficacy, platinum response - Efficacy
drug response
(Dec 7, 2017)
reviewed by expert panel
75.
GRCh37:
Chr16:31103796
GRCh38:
Chr16:31092475
VKORC1warfarin response - Dosagedrug response
(Dec 7, 2017)
reviewed by expert panel
76.
GRCh37:
Chr22:24825511
GRCh38:
Chr22:24429543
ADORA2A, ADORA2A-AS1, SPECC1L-ADORA2Acaffeine response - Toxicity/ADRdrug response
(Dec 20, 2017)
reviewed by expert panel
77.
GRCh37:
Chr1:155279482
GRCh38:
Chr1:155309691
FDPSBisphosphonates response - Efficacydrug response
(Jun 22, 2016)
reviewed by expert panel
78.
GRCh37:
Chr16:69143577
GRCh38:
Chr16:69109674
HAS3anthracyclines and related substances response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
79.
GRCh37:
Chr6:39325078
GRCh38:
Chr6:39357302
KIF6atorvastatin response - Efficacy, pravastatin response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
80.
GRCh37:
Chr19:15990431
GRCh38:
Chr19:15879621
CYP4F2acenocoumarol response - Dosage, phenprocoumon response - Dosage, warfarin response - Dosage,
warfarin response - Other
drug response
(Apr 6, 2018)
reviewed by expert panel
81.
GRCh37:
Chr2:234627608
GRCh38:
Chr2:233718962
UGT1A, UGT1A10, UGT1A8, UGT1A7, UGT1A6, UGT1A5, UGT1A9, UGT1A4lamotrigine response - Otherdrug response
(Dec 7, 2017)
reviewed by expert panel
82.
GRCh37:
Chr11:120663363
GRCh38:
Chr11:120792654
GRIK4not specified, antidepressants response - Efficacydrug response
(Jun 8, 2016)
reviewed by expert panel
83.
GRCh37:
Chr4:69536084
GRCh38:
Chr4:68670366
UGT2B15oxazepam response - Other, lorazepam response - Otherdrug response
(Dec 20, 2017)
reviewed by expert panel
84.
GRCh37:
Chr17:43911525
GRCh38:
Chr17:45834159
CRHR1, LINC02210-CRHR1budesonide response - Efficacy, corticosteroids response - Efficacy, fluticasone propionate response - Efficacy,
fluticasone/salmeterol response - Efficacy, triamcinolone response - Efficacy
drug response
(Apr 7, 2016)
reviewed by expert panel
85.
GRCh37:
Chr6:31543031
GRCh38:
Chr6:31575254
TNFTumor necrosis factor alpha (TNF-alpha) inhibitors response - Efficacy, adalimumab response - Efficacy, etanercept response - Efficacy,
infliximab response - Efficacy
drug response
(Jun 7, 2016)
reviewed by expert panel
86.
GRCh37:
Chr11:113346351
GRCh38:
Chr11:113475629
DRD2not specified, risperidone response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
87.
GRCh37:
Chr18:57851097
GRCh38:
Chr18:60183864
MC4Rantipsychotics response - Toxicity/ADRdrug response
(Sep 22, 2015)
reviewed by expert panel
88.
GRCh37:
Chr16:31105353
GRCh38:
Chr16:31094032
VKORC1warfarin response - Dosagedrug response
(Oct 29, 2014)
reviewed by expert panel
89.
GRCh37:
Chr13:95714976
GRCh38:
Chr13:95062722
ABCC4tenofovir response - Metabolism/PKdrug response
(May 15, 2017)
reviewed by expert panel
90.
GRCh37:
Chr5:74642855
GRCh38:
Chr5:75347030
HMGCRHMG CoA reductase inhibitors response - Efficacy, pravastatin response - Efficacy, simvastatin response - Efficacy
drug response
(Oct 14, 2015)
reviewed by expert panel
91.
GRCh37:
Chr15:45620985
GRCh38:
Chr15:45328787
hmg coa reductase inhibitors response - Toxicity/ADR, simvastatin response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
92.
GRCh37:
Chr17:64788827
GRCh38:
Chr17:66792709
PRKCAhydrochlorothiazide response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
93.
GRCh37:
Chr16:57005479
GRCh38:
Chr16:56971567
CETPHMG CoA reductase inhibitors response - Efficacydrug response
(Jul 11, 2016)
reviewed by expert panel
94.
GRCh37:
Chr8:69389217
GRCh38:
Chr8:68476982
C8orf34irinotecan response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
95.
GRCh37:
ChrX:114138144
GRCh38:
ChrX:114903581
HTR2Cnot specified, antipsychotics response - Toxicity/ADR, clozapine response - Toxicity/ADR,
olanzapine response - Toxicity/ADR, risperidone response - Toxicity/ADR
drug response
(Oct 19, 2017)
reviewed by expert panel
96.
GRCh37:
Chr15:45673029
GRCh38:
Chr15:45380831
GATMhmg coa reductase inhibitors response - Toxicity/ADR, simvastatin response - Toxicity/ADRdrug response
(Jul 11, 2016)
reviewed by expert panel
97.
GRCh37:
Chr22:19929027
GRCh38:
Chr22:19941504
COMT, TXNRD2Selective serotonin reuptake inhibitors response - Efficacydrug response
(Jun 22, 2016)
reviewed by expert panel
98.
GRCh37:
Chr19:39738787
GRCh38:
Chr19:39248147
IFNL3, IFNL4not specified, peginterferon alfa-2a, peginterferon alfa-2b, and ribavirin response - Efficacy, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, and telaprevir response - Efficacy,
peginterferon alfa-2b response - Efficacy, boceprevir response - Efficacy, ribavirin response - Efficacy
drug response
(Apr 5, 2018)
reviewed by expert panel
99.
GRCh37:
Chr10:96405502
GRCh38:
Chr10:94645745
warfarin response - Dosagedrug response
(Mar 9, 2016)
reviewed by expert panel
100.
GRCh37:
Chr10:96521657
GRCh38:
Chr10:94761900
CYP2C19, LOC110599570citalopram response - Metabolism/PK, clopidogrel response - Dosage, Efficacy, Toxicity/ADR, escitalopram response - Metabolism/PK
drug response
(Jun 14, 2016)
reviewed by expert panel
Format
Items per page
Sort by

Download:

Choose Destination
Support Center